Myaderm today announced the launch of CBD Blemish Cream, a new Cannabidiol (CBD) blemish control product.
“Through in-depth studies and extensive real world testing, we know CBD Blemish Control will disrupt the current blemish and acne treatment market by providing a solution that is more effective and gentler on skin than alternatives,” said Eric Smart, CEO of Myaderm, a Colorado based company that uses proven pharmaceutical technologies to create innovative cannabinoid products.
CBD is a non-psychoactive cannabinoid found in the cannabis plant. It is 100% natural and has clinically studied therapeutic benefits in multiple areas. Myaderm is a leader in the application of proven pharmaceutical technologies that deliver CBD safely and effectively for pain and skincare conditions.
CBD is known to inhibit the production of acne-causing oil and reduce inflammation, making it an effective, multifaceted approach to treating blemishes. CBD Blemish Control is formulated by a licensed pharmacist and comprehensive testing has shown dramatic results, providing visible reduction in inflammation and redness in minutes with significantly clearer skin in a few days.
Variable controlled test participants using CBD Blemish Control reported:
- “I can’t believe it’s all-natural and works better than other brands.”
- “I cannot tell you how you made my son’s day with something that works.
It’s hard being a teenager with acne.”
- “Finally, a product that doesn’t feel like it’s hurting my face more than helping it!”
Key characteristics of CBD Blemish Control:
- Every bottle contains organic CBD and organic ingredients.
- There is no maximum dosage; it’s safe to use day and night.
- CBD is legal in all 50 states.
- CBD will not get you high.
Myaderm’s transdermal pain products use the therapeutic properties of Cannabidiol (CBD) for fast acting, all- natural pain relief. Made with absolutely pure CBD and all natural pharmaceutical grade ingredients for long lasting pain relief. No side effects. Myaderm is safe for daily use to reduce inflammation and pain without worrying about negative side effects using the power of CBD.
Chronic pain affects roughly one fifth of the world’s population. In the US alone, 75 million people struggle with the debilitating effects of joint, muscle and nerve pain every day. Nonsteroidal anti-inflammatory drugs (NSAIDs) and other traditional options may provide short-term relief but they often come with potentially serious side effects—forcing those who suffer to settle for less effective options, simply to mitigate the added health risks.
Learn more here: http://cbdblemish.com/
Myaderm uses proven pharmaceutical technologies to create innovative cannabinoid products. The company produces the only brand of pharmacist-formulated, transdermal Cannabidiol (CBD) pain creams on the market today, with new products in the skincare category.
Marketing Manager – Myaderm
88 Inverness Circle East, Suite A101
Englewood, CO 80112